Concepedia

Publication | Open Access

Real-World Outcomes of Belantamab Mafodotin for Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results of a Spanish Expanded Access Program (EAP)

DOIFull Paper Access

15

Citations

12

References

2022

Year

Adrían Alegre, Gonzalo Benzo, Rafael Alonso, Joaquín Martínez‐López, Ana Jiménez Ubieto, Clara Cuéllar, Elham Askari, Elena Prieto, Concepción Aláez, Beatriz Aguado,
Oncology and Therapy

Abstract

BM showed relevant anti-myeloma activity in RRMM with a manageable safety profile. These results corroborate those observed in the BM pivotal trial.

References

YearCitations

Page 1